---
created: 2025-04-13
updated: 2025-04-13T10:53
id: JuJ<?pVaq6
specialty: immuno
specialty_id: 130
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::03-recombinant-cytokines-&-clinical-uses
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::03-recombinant-cytokines-&-clinical-uses::bone-marrow-stimulation::epo
  - "source/ak-step1-v11:": 
  - theme/nbme::free120
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::01-immunology::08-bone-marrow-stimulation
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::immunology-&-biochemistry-pharmacology::immuno-stimulants-&-biochemistry-pharmacology::immunostimulants-(interferons,cytokine-therapy)
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - "source/ak-step2-v11:": 
  - theme/uworld::10000-99999::15000-15999::15324"
type: flashcard
---

# Question
The anemia in Chronic Kidney Disease can be treated with **EPO agents (eg, epoetin alfa)**

---

# Answer
This will effectively reverse the anemia, since the problem with anemia here is loss of interstitial fibroblasts that produce erythropoetin, ie, peritubular interstitial fibroblasts *renal cortex*